Monoclonal antibodies were generated against a synthetic glycoconjugate containing the trisaccharide a-Kdo-(2->8)-a-Kdo-(2->4)-a-Kdo (Kdo, 3-deoxy-D-man/io-2-octulopyranosonic acid) which represents the genus-specific epitope of the lipopolysaccharide from the obligatory intracellular human pathogen Chlamydia. Antibodies of all immunoglobulin G isotypes were obtained and characterized by enzyme immunobinding and inhibition assays using the immunizing antigen as well as chemically synthesized derivatives of the Kdo trisaccharide. The latter contained (1) one of the three residues in P-instead of ot-Iinkage, (2) a Kdo residue the carboxyl group of which had been reduced to a CH 2 OH group (KdOd.,^), or (3) changing the linkage of the terminal Kdo from 2->8 to 2-»4. Only one compound, namely, ot-Kdo-(2->8)-a-Kdo cl _ red -(2->4)-aKdo exhibited binding to and inhibition of Kdo trisaccharide-specific antibodies, whereas all other compounds were not active. Structural and conformational investigations using NMR spectroscopy at high field on the allyl glycosides of the oligosaccharides 6-12 confirmed the conformational similarities between those structures 4, 5, and 10 which were able to bind to the antibodies investigated.
Introduction
Bacteria of the genus Chlamydia are pathogenic, obligatory phagosomal intracellular parasites that cause acute and chronic diseases in animals and humans (Moulder, 1991) . Chlamydia psittaci, C.trachomatis, C.pneumoniae, and C.pecorum are the four species of the monogeneric family Chlamydiaceae. As other gram-negative bacteria, Chlamydiae contain in their outer membrane a lipopolysaccharide (LPS) which is an essential constituent and represents one of the major surface antigens of this microorganism (Nurminen et al, 1983; Caldwell and Hitchcock, 1984) . The LPS contains in its saccharide moiety an antigenic epitope shared by all Chlamydiae, and thus represents a genus-specific antigen. This epitope is composed of a trisaccharide of 3-deoxy-D-manno-2-octulopyranosonic acid (Kdo) of the sequence ot-Kdo-(2-»8)-ot-Kdo-(2-»4)-ot-Kdo (Brade et al., 1995, and references therein) which is biosynthetically assembled by a single, trifunctional Kdo-transferase (Belunis et al., 1992; Ltibau et al., 1995) . The structure has been chemically synthesized and converted into an artificial neoglycoconjugate against which monoclonal antibodies have been prepared. Serological analyses have identified antibodies recognizing the 2-»4-or 2->S-linked disaccharide part structures or the complete trisaccharide (Fu et al., 1992) .
hi order to understand the molecular requirements of Kdo oligosaccharides to bind the latter type of antibodies, derivatives of the native Kdo trisaccharide were synthesized and investigated for their binding capacities. In addition, detailed NMR experiments were performed on the oligosaccharides and the results will be discussed in the context of the serology data.
Results

Immunization of mice and preparation of monoclonal antibodies
BALB/c mice were successfully immunized with a-Kdo-(2->8)-a-Kdo-(2->4)-a-Kdo-(2->6)-P-GlcNAc-(l->6)-aGlcNAc-BSA. Animals were tested on day 50 for serum antibodies against the immunizing antigen. The animal with the highest titer in EIA against the immunizing antigen was used for fusion 3 months later. Spleen cells (2.3 x 10 ) were fused of which 1.1 x 10 8 cells were seeded into 720 primary wells; 128 primary hybridomas were obtained, two of which were further followed. The antibodies bound to chlamydial LPS in (1) immunofluorescence using Chlamydia-infected tissue culture cells, (2) hemagglutination (both data not shown), and (3) EIA using synthetic neoglycoconjugates harboring the genusspecific epitope (see below). After cloning by limiting dilution, monoclonal antibodies were purified by affinity chromatography, checked for purity by SDS-PAGE (data not shown) and isotyped; the isotypes were IgG^ K for clone S40-8 and IgGK for clone S40-26. Thus, together with the antibodies described earlier (Fu et al, 1992; Brade et al, 1990) , all IgG isotypes were represented (Table I) . The results described below were obtained with affinity-purified monoclonal antibodies.
Serological characterization of monoclonal antibodies
Monoclonal antibodies were tested against the neoglycoconjugate antigens by EIA using 2 pmol of ligand per well. The results are shown in Table TL . None of the antibodies reacted with Kdo monosaccharide or the 2-»4-or 2-»8-linked Kdo disaccharide but they all bound to the 2->8-2-M-linked Kdo trisaccharide confirming the strict requirement for all three O Oxford University Press Fu et al., 1992 Fu et al, 1992 Fu et al, 1992 This study This study Brade et al, 1990 "Oligosaccharides were conjugated to bovine serum albumin as described in Material and methods.
Kdo residues. Binding was observed at antibody concentrations in a range of 1 ng/ml (S25-23) to 32 ng/ml (S40 -8) .
The antibodies were then tested against the synthetic analogs and derivatives. As seen in Table n , none of the antibodies bound to a-Kdo- (12), even at high concentrations. Binding was also not observed when EIA plates were coated with higher antigen concentrations of up to 20 pmol per well. To ensure that the antigens had efficiently coated the plastic surface, the monoclonal antibody A20 was included as a positive control. This antibody binds to a single, a-pyranosidically linked Kdo residue (Rozalski et al, 1989) . Clone S25-23 and S4O-26 exhibited binding to a-Kdo-(2->8)-a-Kdo cl _ r?d -(2^4)-a-Kdo (10), though at higher antibody concentrations than with the natural structure a-Kdo-(2-»8)-a-Kdo-(2->4)-a-Kdo (4). Clones S25-5, S25-26, and S5-10 reacted to some extent with a-Kdo-(2-»8)-a-Kdo cl _ red -(2-»4)-a-Kdo (10), however, only when high antigen and antibody concentrations were used.
For further characterization, antibodies S25-23 and S40-26 were investigated by checkerboard titrations using antibody concentrations between 0.5 ng/ml and 1 u,g/ml and antigen coating concentrations between 400 and 3.2 pmol of ligand per ml. The results are shown in Figure 1 . Antibody S25-23 bound with slightly higher affinity than S40-26 to a-Kdo-(2-»8)-aKdo-(2-»4)-a-Kdo (4), particularly when low amounts of antigen were used. Binding to the carboxyl-reduced derivative a-Kdo-(2-»8)-a-Kdo cl _ rc d-(2-44)-a-Kdo (10) was significantly reduced for both antibodies at all antigen concentrations tested.
Finally, inhibition experiments were performed. The results obtained for antibody S25-23 and S40-26 with ot-Kdo-(2->8)-a-Kdo-(2->4)-a-Kdo-BSA as a solid-phase antigen and allyl glycosides as haptenic inhibitors are shown in Figure 2 . (13) gave similar inhibition curves with 50% inhibition values of 0.6 to 1 ixM for S25-23 and 2-6 |xM for S40-26, the carboxyl-reduced derivative a-Kdr>(2^8)-a-Kdo cl _« d -(2^4)-a-Kdo-(l^aUyl (10) was significantly less active with 50% inhibition values of 90 and 60 u-M for S25-23 and S40-26, respectively. All other compounds were not active in concentrations of up to 1 mM (data not shown).
NMR spectroscopy
The structural identity and spectral assignments of compounds 1-5 were reported previously (Bock et al., 1992) . The 'H-NMR data (600 MHz) for solutions of 6-12 in D 2 O at 27°C are given in Table HI . The assignments were based on COSY, Table II . Reactivity of monoclonal antibodies with synthetic neoglycoconjugates containing the CWam)*fta-specific ot-Kdo-<2->8)-a-Kdo-{2->4)-a-Kdo or derivatives thereof Antigen, compound number, and structure* 1 aKdo 2 aKdo(2->4)-aKdo 3 aKdo(2->8)aKdo 4 aKdo(2->8)aKdo(2->4)aKdo 5 aKdo(2->8)aKdo(2->4)aK:do<2->6)BGlcNAc 6 aKdo(2->8)aKdo(2^4)pKdo 7 aKdo(2->8)PKdo(2->4)aKdo 8 BKdo(2->8)aKdo(2-»4)aKdo 9 aKdo{2^8)aKdo(2->4)aKdo cl^rf 10 aKdo{2->8)aKdo clH^-{2->4)aKdo 11 aKdo cl^, ,-(2->8)aKdo{2-44)aKdo U aKdo(2->4)aKdo (2-»4) relayed, and double-relayed COSY experiments, together with phase-sensitive double-quantum-filtered (DQF) COSY experiments as previously reported. The / values (Table HI) indicate that the chair conformations are maintained in the residues A, B, and C for each compound. The 13 C-NMR data (125.77 MHz) are given in Table IV . These assignments were based on heteronuclear correlation spectroscopy with the assigned proton signals and by comparison with data for model compounds.
Results from 2D-NOE or rotating-frame spectroscopy (ROESY) experiments for compounds 6-12 are presented in Table V and confirmed the structural identity by the intraresidue interactions and the spectral assignments. 
Discussion
It is well established that monoclonal antibodies can be generated against the genus-specific epitope of chlamydial LPS by immunizing mice with chlamydial elementary bodies (Caldwell and Hitchcock, 1984; Brade et al, 1990) or synthetic neoglycoconjugates containing the trisaccharide a-Kdo-(2->8)-a-Kdo-(2-»4)-a-Kdo (Fu et al, 1992) . Such immunizations led to the induction of antibodies recognizing part structures of this trisaccharide such as Kdo monosaccharide, the 2-^4-or 2-»8-linked Kdo disaccharide or the Kdo trisaccharide. Interestingly, using glycoconjugates containing just the Kdo trisaccharide, we never succeeded to induce the latter type of antibody, although the saccharide had been coupled through a cysteamine spacer arm (unpublished observation).
On the other hand, using conjugates containing the tetrasac- (Fu et al., 1992) or the pentasaccharide a-Kdo-
GlcNAc (this study), antibodies recognizing more complex structures than the trisaccharide were also not observed. Obviously, the chlamydial LPS is an extremely potent immunogen with pronounced immunodominance of the Kdo trisaccharide. This is not only the case for experimentally immunized animals but also for patients with chlamydial infections. The antibodies directed against this epitope are of tremendous importance in medical microbiology for the diagnosis of chlamydial infections and of interest for understanding the recognition of carbohydrates by proteins in general (Toone, 1994; Peters and Pinto, 1996) and by antibodies in particular (Cygler et al., 1991; Vyas et al., 1993) . Therefore, we synthesized a variety of artificial derivatives and analogues of this Kdo trisaccharide. Since it is well known that the anomeric configuration is critical in determining the specificity of immunodominant sugar residues in carbohydrate antigens and since we knew from earlier investigations that the charge provided by the carboxyl group is crucial for antigenicity, modifications concerned these structural properties. In addition, the 2-^4-2-»4-linked Kdo trisaccharide 12 was included in this study since this structure occurs also in other LPS. The serological data clearly indicated the absolute requirement of three Kdo residues for binding. Moreover, the fact that all derivatives, except a-Kdo-(2-*8)-a-Kdo cl _ red -(2^4)-aKdo, did not bind any of the antibodies investigated, pointed to the importance of distinct structural features in the determination of specificity. Therefore, those oligosaccharides showing binding in serology were further investigated by NMR spectroscopy (Peters and Pinto, 1996) .
The orientation of the side chain in the Kdo residues, as determined from the coupling constants J 61 , J 1%tL , and J lgb in the model monosaccharides, show that the oligosaccharides 7 and 12 are different from that in residue B of compounds 6, 8, and 9 and with intermediate values for 10 and 11, where, in particular, the J 6J value of 5.6 Hz ± 0.4 Hz (cf. -8.5 Hz ± 0.5 Hz in the model mono-or disaccharides) indicates a substantial change of the rotamer population away from the preponderating fra/u-orientation between H6 and H7. Inspection of models computed by the HSEA calculations suggest that this change in orientation is due most likely to a strong interaction of (2-»8)-linked Kdo unit A and the aglycone of the Kdo unit C (allyl) as previously reported (Vinogradov et al, 1994) . Such a longrange interaction with the possibility for relief through multiple minor rotations about bonds in the side chain and the glyco- sidic linkages was not expected to result in such a substantial change in conformation.
The only active compound among the new series (6-12) with respect to antibody binding is compound 10 as seen from Table II . Analysis of the NMR data (Tables m, IV) , compared with the data published previously on compound 4 (Bock et al, 1992) show only major deviations for the proton chemical shifts (>0.10 ppm) for protons H6, H7, and H8 for residue B together with the coupling constant J 6 7 of 7.8 Hz for 10 compared to 5.1 Hz for 4 and for carbon chemical shifts (>0.6 ppm) for C5, C7 and C8 in residue B. All these changes are in clear agreement with a minor change in the population of the conformational preference of the side-chain for residue B in 10 compared to 4, but the overall shape of the molecule is predominantly as previously described for 4, and therefore, the interaction with the antibody is measurable. It is interesting to note that the relative larger population in 10 of the "normal" conformation with J 6 7 about 9 Hz compared to compound 4 is also reflected in the somewhat inferior binding data to the antibodies.
All the NOE data presented in Table V are in full accord with these suggestions. Compared to compound 4 it was possible to observe strong interunit NOE effects between protons in residues A and B in compound 10; the results confirm the previously reported conformational preferences for compound 4 with cross peaks between H8B and H6A and H8A, and more importantly, the long-range interaction between H8B and H6C as indicated in Figure 3 confirms the contribution from the "back-folded" conformation. The other changes in chemical shift observed on comparison of compound 10 with the data for compound 4 are trivially related to the change of Cl in residue B from a carboxylic acid to a hydroxymethyl group. The more detailed NMR analyses of compounds 7 and 8 as shown in Figure 3 are in full accordance with the above discussed observations, and the data do not suggest that the shape of these molecules should be similar to those of compounds 4 or 10, and therefore, no measurable binding to the antibodies was observed.
L.Brade el aL
Further data, in particular NMR experiments on the antigenantibody complex or crystallographic data, will contribute to understand this interesting protein-carbohydrate interaction at the atomic level.
Materials and methods
Synthetic oligosaccharides and neoglycoconjugate antigens
The synthetic oligosaccharides 1 a-Kdo-<2-»aUyl (Kdo = 3-deoxy-D-manno-2-octulo-pyranosylonic acid), 2 a-Kdo-(2-*4)-a-Kdo-{2-»allyl, 3 a-Kdo-(2->8)-a-Kdo-(2-»allyl, 4 a-Kdo-{2->8)-a-Kdo-(2->4)-a-Kdo-(2-+allyl, 5 a-Kdo-(2->8)-a-Kdo-(2->4)-a-Kdo-(2->6)-P-GlcNAc-(l->allyl, 6 a-Kdo-(2->8)-a-Kdo-(2->4)-P-Kdo-(2->allyl, 7 a-Kdo-(2->8)-P-Kdo-(2->4)-a-Kdo-(2-»allyl, 8 P-Kdo-(2-»8)-a-Kdo-(2-»4)-a-Kdo-(2->allyl, 9 a-Kdo-(2->8)-a-Kdo-(2-»4)-a-Kdo cl _ rod -(2-^allyl, 10 a-Kdo-(2-»8)-aKdo ci-™d-(2->4)-a-Kdo-(2(allyl, 11 a-Kdo c ,^s d -(2^8)-a-Kdo-(2->4)-aKdo-(2-»allyl, 12 a-Kdo-(2->4)-a-Kdo-(2-»4)-a-Kdo-(2->allyl, and 13 a-Kdo-(2-»8)-ct-Kdo-(2->4)-cr-Kdo-(2->6)-B-GlcNAc-( 1 -w5)-a-GlcNAc-(1-•allyl, were synthesized as described previously (Kosma etaL, 1988 (Kosma etaL, , 1989 (Kosma etaL, , 1990 (Kosma etaL, , 1994 D'Souza et al., 1994) . The allyl glycosides R-CH 2 -CH = CH 2 were conjugated with cysteamine (Lee and Lee, 1974) yielding R^CHJVS-(CHJ^-NH , which was activated with thiophosgen into the isothiocyanate derivatives R^CH^-S-CCH^-N = C = S and then conjugated to bovine serum albumin (BSA) yielding RKCH^J-SKCHJ^-NH-CS-NH-BSA, wherein R represents the glycosyl residue. The latter compounds will be abbreviated as R-BSA. The amount of ligand present in the conjugates was determined by measuring the amount of protein (Bradford assay, Bio-Rad) and Kdo (thiobarbiturate assay). 6, 7, 8, and 12 A solution of the respective allyl glycoside and cysteamine hydrochloride in water (0.1 ml) was stirred under UV irradiation (254 run) in a quartz vial for 12 h at room temperature. The solution was applied onto a column (5 x 0.5 cm) of Dowex AG WX8 (ammonium-form) and successively eluted with water and 0.1 M NH 3 . Fractions (1.5 ml) were collected and neutralized by addition of 0.1 M NH 3 . The first fraction contained mainly the unreacted allyl glycoside, followed by the spacer derivative, and finally free cysteamine. Appropriate fractions were pooled, concentrated and purified on a column of Bio-Gel P2 (100 x 2.5 cm, water/EtOH, 95:5 by volume).
Synthesis of [S-{2-aminocthyl)-3-thiopropyl] derivatives
Yield for spacer derivative 6 (9.6 mgof allyl glycoside 6 and 30 mg of HS(CHJ 2 NH 2 .HC1): 8.5 mg (79%), [a] 5 * +50" (c 0.2, H 2 O). 'H NMR (300 MHz, D 2 O) 20 H, H^, 4', 4', 5, 5', 5', 6, 6', 6', 7, 7', 7', 8a, 8'a, 8'a, 8b, 8'b, 8"b, OCH 2 .64 (2C, C-2,2',2*), 74.07 (C-6), 73.01 (C-6'), 72.24 (C-6"), 71.14 (C-4), 70.78, 70.48 (C-7',7') , 69.98 (C-7), 67.94 (C-5'), 67.28 (C-5"). 66.68 (2C,C-4', 4*), 64.89 (C-8',8) , 64.21 (C-5*), 63.65 (OCH 2 C-8"), 39.21 (NCH 2 ), 29.75 (SCHJ, 29.24 (CHJ, 28.14 (SCHJ. Yield for spacer compound 7 (11.5 mg of allyl glycoside 7 and 21 mg of HS(CH 2 ) 2 NH 2 .Ha): 11.1 mg (86%), [a]** +68° (c 1.1, H 2 O) 'H NMR (300 MHz, D 2 O) : 8 4.23 (d, 1H, H-5), 4.19-4.12 (m, 2H, H-4, 4*), 4.07-3.90 (m, 7H, H-5', 5", 7, 7', 7", 8'a, 8'a), 3.77 (dd, 2H, J 6 . 7 . = ls-T = 8.5, J 6 . y = JPJ. = 1.0 Hz, H-6', 6"), 4H, 8'b, 8"b, 8'a), 3.60 (dd, 1H, J 6j = 10. Js.7 = 9.0 Hz, 2H, OCH 2 ), 3.33 (m, 1H, OCH 2 ), 3.23 (t, 1H, NCHJ, 2.88 (t, 2H, SCH 2 LJJrade et al HS(CH) 2 NH 2 .HC1): 1.9 mg (98%). 'H NMR (300 MHz, D 3 O) 22H, ring protons, l"b, 3.24 (t, 2H, J = 65 Hz, NCHj), 2.87 (t, 2H, SCHj), 2.69 (t, 2H, SCHj), 2H, 3», 6H, 3'a, To, 3"e, CHj) .
Synthesis of BSA conjugates
A solution of thiophosgene (2 \xl) in CHQ 3 (2 ml) was added to a solution of the spacer derivative in 0.1 M aqueous NaHCO 3 (1.5 ml) and vigorously stirred for 4 h at room temperature. The organic phase was separated, the aqueous layer was washed three times with CHC1 3 (2 ml portions) and purged with N 2 until a clear solution was obtained. The solution was transferred to a solution of BSA (Sigma) in aqueous 0.1 M NaHCOj/0.3 M NaCl (1 ml). The solutions were stirred slowly at room temperature for 72 h, and then passed through a Sephadex G-25 column (1.6 x 50 cm, 0.1 M NaHCOj). Ninhydrine-positive fractions were pooled and dialyzed two times against distilled water (2 1) for 24 h. Lyophilization gave the BSA-conjugates as fluffy white powders.
Yield for 6-BSA: 4.5 mg (4.0 mg of spaceT compound 6 and 5.0 mg of BSA); 7-BSA: 3.5 mg (3.5 mg of spacer compound 7 and 2.5 mg of BSA); 8-BSA: 6.7 mg (5.4 mg of spacer compound 8 and 5.3 mg of BSA); 9-BSA: 6.0 mg (2.9 mg of spacer compound 9 and 5.0 mg of BSA); 10-BSA: 5.5 mg (4.2 mg of spacer compound 10 and 5.5 mgof BSA); ll-BSA:4.6mg(1.9 mg of spacer compound 11 and 4.0 mg of BSA); 12-BSA: 4.2 mg (3.8 mg of spacer compound 12 and 35 mg of BSA)
Monoclonal antibodies
Monoclonal antibodies S25-23, S25-5,and S25-26, prepared by conventional protocols after immunization with synthetic a-Kdo-<2-»8)-a-Kdo-<2-»4)-aKdo-(2-»6>fJ-GlcNAc-BSA have been already described (Fu et al, 1992) . According to the same protocol, mice were immunized with a-Kdo-{2->8)-aKdo-(2->4)-a-Kdo-<2-»6>P-GlcNAc-<l->6)-a-GlcNAc-BSA; from this fusion two additional antibodies, named S4O-8 and S40-26, were obtained using the same screening protocol as before (Fu et aL, 1992) . The Kdo trisaccharidespecific monoclonal antibody S5-10 was obtained after immunization with Chlamydia psittaci (Brade et aL, 1990) . Antibodies were harvested from hybridoma culture supernatants, purified by affinity chromatography and isotyped using a commercial isotyper kit (Bio-Rad). The Kdo monosaccharidespecific monoclonal antibody A20 (IgM) was included as a control (Rozalski et aL, 1989) .
Affinity chromatography
Monoclonal antibodies were purified by affinity chromatography using the trisaccharide 4 as a ligand immobilized on AH-Sepharose 4B by me glutardialdehyde method as follows. AH-Sepharose 4B (Pharmacia, 500 mg) was suspended in NaCl (0.5 M, 10 ml) overnight and washed four times in the same solvent. Glutardialdehyde (electron microscopy grade, Darmstadt; 3 ml, 10% in water) was added, left on an overhead shaker for 1 h at room temperature, and washed five times with water. The ligand (10 mg), dissolved in carbonate buffer (50 mM, pH 9.2, 2 ml), was added to the slurry and left on an overhead shaker over night at room temperature. The supernatant and the first two washings were kept for chemical analysis. In a typical experiment, 50-70% of the ligand was bound. Remaining aldehyde groups on the sepharose were blocked with glycine (1M,2 ml) for 1 h at room temperature. After washing with water, the Schiff s bases formed were reduced wirh sodium borohydride (2 ml, 10% in 10 mM NaOH) and left 1 h at room temperature in the dark. Excess borohydride was destroyed at 4°C with acetic acid (10%) followed by washing in water. Storage of the product was in 1 M NaCl with 0.1% sodium azide at 4°C. The sepharose was filled into a small column (0.7 x 5 cm), washed with 5 bed volumes of Tris buffer (10 mM, pH 7.5), and loaded with hybridoma culture fluid supernatant using a pump at a flow rate of 0.5 ml/min. Fractions were tested for unbound antibody. The column was washed (1 ml/ min) with 20 bed volumes of Tris buffer then with 20 bed volumes of Tris buffer supplemented with NaCl (0.5 M) and eluted (0.5 ml/min) first with glycine/HCl (0.1 M, pH 3.2, 15 ml) and then with glycine/HCl (0.1 M, pH 2.7, 10 ml). Fractions were collected, the pH adjusted to 5.0 with sodium bicarbonate, and tested for antibody activity. Appropriate fractions were combined, purity of the isolated antibodies was confirmed by SDS-PAGE using a 10% separating gel in the Laemmli system followed by staining with Coomassie brilliant blue. Antibody concentrations were determined by a commercially available protein assay (Bio-Rad) according to die supplier's instructions. Purified antibodies were stored in aliquots at -20°C. The column was regenerated with glycine/HCl (0.1 M, pH 2.3, 10 ml).
Serology
For enzyme immunoassays (EIA), neoglycoconjugates were coated onto MaxiSorp microtiter plates (U-bottom, Nunc). Antigen solutions were adjusted to equimolar concentrations based on the amount of ligand present in the respective glycoconjugate. Unless stated otherwise, 50 uJ volumes were used. Microtiter plates were coated wim the respective antigen solution in 50 mM carbonate-buffer pH 9.2 at 4°C over night. Plates were washed twice with distilled water, further washing was done in PBS supplemented with 0.05% Tween 20 (Bio-Rad) and 0.01% thimerosal (PBS-T). Plates were then blocked with PBS-T supplemented with 2.5% casein (PBS-TQ for 1 h at 37°C on a rocker platform followed by two washings. Appropriate antibody dilutions in PBS-TC supplemented with 5% BSA (PBS-TCB) were added and incubated for 1 h at 37°C. After washing, peroxidase-conjugated goat anti-mouse immunoglobulin (Ig) G (heavy-and light chain specific, Dianova) was added (diluted 1:1,000) and incubation was continued for 1 h at 37°C. After three washings in PBS-T, the plates were washed in substrate buffer (0.1 M sodium citrate, pH 4.5). Substrate solution was freshly prepared and was composed of azino-di-3-ethylbenzthiazolinsulfonic acid (1 mg) dissolved in substrate buffer (1 ml) with sonication in an ultrasound water bath for 3 min followed by the addition of hydrogen peroxide (25 u.1 of a 0.1 % solution). After 30 min at 37°C, the reaction was stopped by the addition 2%aqueous oxalic acid and the plates were read by a microplate reader (Dynatech MR 5000) at 405 run.
For EIA inhibition, serial 2-fold dilutions of inhibitor in PBS-TCB (30 p.1) were mixed in V-shaped microtiter plates (NUNC) with an equal volume of antibody diluted in the same buffer to give an OD,^ of 1.0 without the addition of inhibitor. After incubation (15 min, 37°C), 50 u,l of the mixture were added to antigen-coated EIA plates. Further steps were as described before. All measurements were done in triplicates; confidence values never exceeded 10%.
NMR spectroscopy
Structural and spectral assignments were made on samples of ~5 mg in D 2 O (0.5 ml). Spectra were recorded at 27°C and pH -7-8 in 5 mm tubes at 500.13 or 600.13 MHz for 'H-NMR and 125.77 or 150.9 MHz for 13 C-NMR with a Bruker AM 500 or AMX 600 spectrometer, respectively. The 'H resonances were measured relative to internal acetone (2.225 ppm, DOH at 4.75 ppm at 27°C) and coupling constants (±0. 3 Hz) were determined on a first-order basis. The 13 C resonances were reported relative to internal dioxane (67.4 ppm). The spectra were recorded and assigned as previously described (Vinogradov et aL, 1994) .
